Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-14-045643
Filing Date
2014-06-12
Accepted
2014-06-12 16:11:39
Documents
1
Period of Report
2014-06-10

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3820
  Complete submission text file 0001104659-14-045643.txt   5367
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004
Business Address
McGuigan Christopher (Reporting) CIK: 0001412484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 14907362